Role of antibiotics in the management of inflammatory bowel disease: a review [0.03%]
抗生素在炎症性肠病管理中的作用：综述
David T Rubin,Asher Kornblunth
David T Rubin
The current model of pathogenesis for inflammatory bowel disease (IBD) is a dysregulated immune system that is triggered by an environmental factor in a genetically susceptible individual. Although much about this model remains unproven, it...
Paradigm shifts in GI disease management: new information, new opportunities. Introduction [0.03%]
胃肠病管理的范式转变：新信息与新机遇简介
David A Johnson
David A Johnson
Edward C Oldfield rd
Edward C Oldfield rd
Edward C Oldfield rd
Edward C Oldfield rd
Functional gastrointestinal disorders in 2007 and Rome III: something new, something borrowed, something objective [0.03%]
功能性胃肠病2007与罗马Ⅲ标准：新知识、旧观念和客观性问题
Nicholas J Talley
Nicholas J Talley
This review highlights the changes recommended by Rome III to the criteria for the functional gastrointestinal disorders and summarizes the practical implications for clinical practice. The committee retained functional dyspepsia as an umbr...
Christine L Frissora
Christine L Frissora
Irritable bowel syndrome (IBS) is a difficult disease to treat because of its ill-defined triggers, variable clinical course, and unpredictable myriad of symptoms of varying severity. Both doctors and patients are frustrated by the insidiou...
Georgios I Papachristou,Todd H Baron
Georgios I Papachristou
The currently available endoscopic treatment modalities for the palliation of malignant dysphagia outside of self-expandable stent placement are, as yet, not optimal for achieving rapid and sustained dysphagia relief with minimal morbidity ...
Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy [0.03%]
慢性乙型肝炎并重度纤维化或肝硬化患者的抗病毒治疗效果
Gaurav Arora,Emmet B Keeffe
Gaurav Arora
Chronic hepatitis B virus (HBV) infection is a significant public health problem in the United States, with 1.25 million people infected with the virus. The long-term risks of chronic HBV infection include cirrhosis and hepatocellular carci...
William J Sandborn
William J Sandborn
Clinical perspectives in Crohn's disease. Objective measures of disease activity: alternatives to symptom indices [0.03%]
克罗恩病的临床观点。疾病活动度的客观测量：症状指数的替代方法
Edward V Loftus Jr
Edward V Loftus Jr
Advances in fecal and serum inflammatory biomarkers, endoscopy, and radiology have led to a rapid expansion of modalities for diagnosis and disease activity assessment of Crohn's disease. Although no test is recognized as the most accurate ...